R Scott Bitner

Author PubWeight™ 7.89^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.	J Pharmacol Exp Ther	2004	1.33
2	Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties.	CNS Neurosci Ther	2008	0.96
3	Nicotinic acetylcholine receptor agonists: a potential new class of analgesics.	Curr Top Med Chem	2004	0.90
4	Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist.	J Pharmacol Exp Ther	2012	0.88
5	Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization.	J Pharmacol Exp Ther	2003	0.85
6	Analysis of gene expression profiles in rat hippocampus following treatment with nicotine and an alpha7 nAChR selective agonist.	Neurosci Res	2007	0.82
7	Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model.	Pharmacol Biochem Behav	2002	0.78
8	Central oxytocinergic and dopaminergic mechanisms regulating penile erection in conscious rats.	Pharmacol Biochem Behav	2005	0.75
9	Neuronal nicotinic receptors: filling the void?	Am J Physiol Regul Integr Comp Physiol	2003	0.75